- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Radiopharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Radiopharmaceutical size is estimated to be xx million in 2021 from USD 6595.7 million in 2020, with a change of XX% between 2020 and 2021. The global Radiopharmaceutical market size is expected to grow at a CAGR of 8.2% for the next five years.
Market segmentation
Radiopharmaceutical market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Market segment by Application can be divided into
Oncology
Cardiology
Other
The key market players for global Radiopharmaceutical market are listed below:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales, revenue and global market share of Radiopharmaceutical in 2018 and 2019.
Chapter 3, the Radiopharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceutical Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceutical Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size & Forecast
1.4.1 Global Radiopharmaceutical Sales in Value (2016-2026))
1.4.2 Global Radiopharmaceutical Sales in Volume (2016-2026)
1.4.3 Global Radiopharmaceutical Price by Type (2016-2026) & (USD/Dose)
1.5 Global Radiopharmaceutical Production Capacity Analysis
1.5.1 Global Radiopharmaceutical Total Production Capacity (2016-2026)
1.5.2 Global Radiopharmaceutical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiopharmaceutical Market Drivers
1.6.2 Radiopharmaceutical Market Restraints
1.6.3 Radiopharmaceutical Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceutical Product and Services
2.1.4 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Radiopharmaceutical Product and Services
2.2.4 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Radiopharmaceutical Product and Services
2.3.4 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Radiopharmaceutical Product and Services
2.4.4 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Radiopharmaceutical Product and Services
2.5.4 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Radiopharmaceutical Product and Services
2.6.4 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Radiopharmaceutical Product and Services
2.7.4 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radiopharmaceutical Product and Services
2.8.4 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Radiopharmaceutical Product and Services
2.9.4 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Radiopharmaceutical Product and Services
2.10.4 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Radiopharmaceutical Product and Services
2.11.4 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Radiopharmaceutical Product and Services
2.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Radiopharmaceutical Product and Services
2.13.4 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceutical Product and Services
2.14.4 Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Radiopharmaceutical Product and Services
2.15.4 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Radiopharmaceutical Sales by Manufacturer
3.1 Global Radiopharmaceutical Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Radiopharmaceutical Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Radiopharmaceutical
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
3.4.2 Top 6 Radiopharmaceutical Manufacturer Market Share
3.5 Global Radiopharmaceutical Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Radiopharmaceutical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Radiopharmaceutical Market Size by Region
4.1.1 Global Radiopharmaceutical Sales in Volume by Region (2016-2026)
4.1.2 Global Radiopharmaceutical Revenue by Region (2016-2026)
4.2 North America Radiopharmaceutical Revenue (2016-2026)
4.3 Europe Radiopharmaceutical Revenue (2016-2026)
4.4 Asia-Pacific Radiopharmaceutical Revenue (2016-2026)
4.5 South America Radiopharmaceutical Revenue (2016-2026)
4.6 Middle East and Africa Radiopharmaceutical Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Radiopharmaceutical Sales in Volume by Type (2016-2026)
5.2 Global Radiopharmaceutical Revenue by Type (2016-2026)
5.3 Global Radiopharmaceutical Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Radiopharmaceutical Sales in Volume by Application (2016-2026)
6.2 Global Radiopharmaceutical Revenue by Application (2016-2026)
6.3 Global Radiopharmaceutical Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Radiopharmaceutical Sales by Type (2016-2026)
7.2 North America Radiopharmaceutical Sales by Application (2016-2026)
7.3 North America Radiopharmaceutical Market Size by Country
7.3.1 North America Radiopharmaceutical Sales in Volume by Country (2016-2026)
7.3.2 North America Radiopharmaceutical Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Radiopharmaceutical Sales by Type (2016-2026)
8.2 Europe Radiopharmaceutical Sales by Application (2016-2026)
8.3 Europe Radiopharmaceutical Market Size by Country
8.3.1 Europe Radiopharmaceutical Sales in Volume by Country (2016-2026)
8.3.2 Europe Radiopharmaceutical Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Radiopharmaceutical Sales by Type (2016-2026)
9.2 Asia-Pacific Radiopharmaceutical Sales by Application (2016-2026)
9.3 Asia-Pacific Radiopharmaceutical Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceutical Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Radiopharmaceutical Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Radiopharmaceutical Sales by Type (2016-2026)
10.2 South America Radiopharmaceutical Sales by Application (2016-2026)
10.3 South America Radiopharmaceutical Market Size by Country
10.3.1 South America Radiopharmaceutical Sales in Volume by Country (2016-2026)
10.3.2 South America Radiopharmaceutical Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Radiopharmaceutical Sales by Type (2016-2026)
11.2 Middle East & Africa Radiopharmaceutical Sales by Application (2016-2026)
11.3 Middle East & Africa Radiopharmaceutical Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceutical Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Radiopharmaceutical Typical Distributors
12.3 Radiopharmaceutical Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Revenue by Type, (USD Million), 2021-2026
Table 2. Global Radiopharmaceutical Revenue by Application, (USD Million), 2021-2026
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceutical Product and Services
Table 6. Bracco Imaging Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Radiopharmaceutical Product and Services
Table 10. Bayer Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Radiopharmaceutical Product and Services
Table 14. Mallinckrodt Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Radiopharmaceutical Product and Services
Table 18. Nordion Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Radiopharmaceutical Product and Services
Table 22. Triad Isotopes Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Radiopharmaceutical Product and Services
Table 26. Lantheus Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. IBA Group Basic Information, Manufacturing Base and Competitors
Table 28. IBA Group Major Business
Table 29. IBA Group Radiopharmaceutical Product and Services
Table 30. IBA Group Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Radiopharmaceutical Product and Services
Table 34. GE Healthcare Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 36. China Isotope & Radiation Major Business
Table 37. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 38. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Jubilant Pharma Major Business
Table 41. Jubilant Pharma Radiopharmaceutical Product and Services
Table 42. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Radiopharmaceutical Product and Services
Table 46. Eli Lilly Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Radiopharmaceutical Product and Services
Table 50. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 52. SIEMENS Major Business
Table 53. SIEMENS Radiopharmaceutical Product and Services
Table 54. SIEMENS Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 56. Dongcheng Major Business
Table 57. Dongcheng Radiopharmaceutical Product and Services
Table 58. Dongcheng Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Navidea Basic Information, Manufacturing Base and Competitors
Table 60. Navidea Major Business
Table 61. Navidea Radiopharmaceutical Product and Services
Table 62. Navidea Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Radiopharmaceutical Sales by Manufacturer (2019-2021e) & (M Doses)
Table 64. Global Radiopharmaceutical Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Radiopharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Radiopharmaceutical Production Capacity by Company, (M Doses): 2020 VS 2021
Table 67. Head Office and Radiopharmaceutical Production Site of Key Manufacturer
Table 68. Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 69. Radiopharmaceutical Mergers & Acquisitions in the Past Five Years
Table 70. Global Radiopharmaceutical Sales by Region (2016-2021e) & (M Doses)
Table 71. Global Radiopharmaceutical Sales by Region (2021-2026) & (M Doses)
Table 72. Global Radiopharmaceutical Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Radiopharmaceutical Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Radiopharmaceutical Sales by Type (2016-2021e) & (M Doses)
Table 75. Global Radiopharmaceutical Sales by Type (2021-2026) & (M Doses)
Table 76. Global Radiopharmaceutical Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Radiopharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Radiopharmaceutical Price by Type (2016-2021e) & (USD/Dose)
Table 79. Global Radiopharmaceutical Price by Type (2021-2026) & (USD/Dose)
Table 80. Global Radiopharmaceutical Sales by Application (2016-2021e) & (M Doses)
Table 81. Global Radiopharmaceutical Sales by Application (2021-2026) & (M Doses)
Table 82. Global Radiopharmaceutical Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Radiopharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Radiopharmaceutical Price by Application (2016-2021e) & (USD/Dose)
Table 85. Global Radiopharmaceutical Price by Application (2021-2026) & (USD/Dose)
Table 86. North America Radiopharmaceutical Sales by Country (2016-2021e) & (M Doses)
Table 87. North America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 88. North America Radiopharmaceutical Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Radiopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Radiopharmaceutical Sales by Type (2016-2021e) & (M Doses)
Table 91. North America Radiopharmaceutical Sales by Type (2021-2026) & (M Doses)
Table 92. North America Radiopharmaceutical Sales by Application (2016-2021e) & (M Doses)
Table 93. North America Radiopharmaceutical Sales by Application (2021-2026) & (M Doses)
Table 94. Europe Radiopharmaceutical Sales by Country (2016-2021e) & (M Doses)
Table 95. Europe Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 96. Europe Radiopharmaceutical Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Radiopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Radiopharmaceutical Sales by Type (2016-2021e) & (M Doses)
Table 99. Europe Radiopharmaceutical Sales by Type (2021-2026) & (M Doses)
Table 100. Europe Radiopharmaceutical Sales by Application (2016-2021e) & (M Doses)
Table 101. Europe Radiopharmaceutical Sales by Application (2021-2026) & (M Doses)
Table 102. Asia-Pacific Radiopharmaceutical Sales by Region (2016-2021e) & (M Doses)
Table 103. Asia-Pacific Radiopharmaceutical Sales by Region (2021-2026) & (M Doses)
Table 104. Asia-Pacific Radiopharmaceutical Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Radiopharmaceutical Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Radiopharmaceutical Sales by Type (2016-2021e) & (M Doses)
Table 107. Asia-Pacific Radiopharmaceutical Sales by Type (2021-2026) & (M Doses)
Table 108. Asia-Pacific Radiopharmaceutical Sales by Application (2016-2021e) & (M Doses)
Table 109. Asia-Pacific Radiopharmaceutical Sales by Application (2021-2026) & (M Doses)
Table 110. South America Radiopharmaceutical Sales by Country (2016-2021e) & (M Doses)
Table 111. South America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 112. South America Radiopharmaceutical Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Radiopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Radiopharmaceutical Sales by Type (2016-2021e) & (M Doses)
Table 115. South America Radiopharmaceutical Sales by Type (2021-2026) & (M Doses)
Table 116. South America Radiopharmaceutical Sales by Application (2016-2021e) & (M Doses)
Table 117. South America Radiopharmaceutical Sales by Application (2021-2026) & (M Doses)
Table 118. Middle East & Africa Radiopharmaceutical Sales by Country (2016-2021e) & (M Doses)
Table 119. Middle East & Africa Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 120. Middle East & Africa Radiopharmaceutical Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Radiopharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Radiopharmaceutical Sales by Type (2016-2021e) & (M Doses)
Table 123. Middle East & Africa Radiopharmaceutical Sales by Type (2021-2026) & (M Doses)
Table 124. Middle East & Africa Radiopharmaceutical Sales by Application (2016-2021e) & (M Doses)
Table 125. Middle East & Africa Radiopharmaceutical Sales by Application (2021-2026) & (M Doses)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Radiopharmaceutical Typical Distributors
Table 129. Radiopharmaceutical Typical Customers
List of Figures
Figure 1. Radiopharmaceutical Picture
Figure 2. Global Radiopharmaceutical Sales Market Share by Type in 2020
Figure 3. Actinium-225
Figure 4. Lutetium-177
Figure 5. Radium-223
Figure 6. Holmium-166
Figure 7. Other
Figure 8. Global Radiopharmaceutical Sales Market Share by Application in 2020
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Radiopharmaceutical Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 13. Global Radiopharmaceutical Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Radiopharmaceutical Sales (2016-2026) & (M Doses)
Figure 15. Global Radiopharmaceutical Price by Type (2016-2026) & (USD/Dose)
Figure 16. Global Radiopharmaceutical Production Capacity (2016-2026) & (M Doses)
Figure 17. Global Radiopharmaceutical Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Radiopharmaceutical Market Drivers
Figure 19. Radiopharmaceutical Market Restraints
Figure 20. Radiopharmaceutical Market Trends
Figure 21. Global Radiopharmaceutical Sales Market Share by Manufacturer in 2020
Figure 22. Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2020
Figure 23. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Radiopharmaceutical Sales Market Share by Region (2016-2026)
Figure 27. Global Radiopharmaceutical Revenue Market Share by Region (2016-2026)
Figure 28. North America Radiopharmaceutical Revenue (2016-2026) & (USD Million)
Figure 29. Europe Radiopharmaceutical Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Radiopharmaceutical Revenue (2016-2026) & (USD Million)
Figure 31. South America Radiopharmaceutical Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Radiopharmaceutical Revenue (2016-2026) & (USD Million)
Figure 33. Global Radiopharmaceutical Sales Market Share by Type (2016-2026)
Figure 34. Global Radiopharmaceutical Revenue Market Share by Type (2016-2026)
Figure 35. Global Radiopharmaceutical Price by Type (2016-2026) & (USD/Dose)
Figure 36. Global Radiopharmaceutical Sales Market Share by Application (2016-2026)
Figure 37. Global Radiopharmaceutical Revenue Market Share by Application (2016-2026)
Figure 38. Global Radiopharmaceutical Price by Application (2016-2026) & (USD/Dose)
Figure 39. North America Radiopharmaceutical Sales Market Share by Type (2016-2026)
Figure 40. North America Radiopharmaceutical Sales Market Share by Application (2016-2026)
Figure 41. North America Radiopharmaceutical Sales Market Share by Country (2016-2026)
Figure 42. North America Radiopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 43. United States Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Radiopharmaceutical Sales Market Share by Type (2016-2026)
Figure 47. Europe Radiopharmaceutical Sales Market Share by Application (2016-2026)
Figure 48. Europe Radiopharmaceutical Sales Market Share by Country (2016-2026)
Figure 49. Europe Radiopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 50. Germany Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Radiopharmaceutical Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Radiopharmaceutical Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Radiopharmaceutical Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Radiopharmaceutical Revenue Market Share by Region (2016-2026)
Figure 59. China Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Radiopharmaceutical Sales Market Share by Type (2016-2026)
Figure 66. South America Radiopharmaceutical Sales Market Share by Application (2016-2026)
Figure 67. South America Radiopharmaceutical Sales Market Share by Country (2016-2026)
Figure 68. South America Radiopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Radiopharmaceutical Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Radiopharmaceutical Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Radiopharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
